Advanced Search

Seasonal/Pandemic Influenza Stocks List

Symbol Grade Name % Change
INO F Inovio Pharmaceuticals, Inc. 0.44
VBIV F VBI Vaccines Inc. 3.69
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Influenza Influenza Vaccine Medicine Vaccination Vaccine Virology Avian Influenza Biotechnology Cancers Cervical Cancer Clinical Research Coronavirus Cytomegalovirus Infection Diseases Electroporation Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Immunodeficiency

Related ETFs - A few ETFs which own one or more of the above listed Seasonal/Pandemic Influenza stocks.

Symbol Grade Name Weight
GERM D ETFMG Treatments Testing and Advancements ETF 3.59
MOON D Direxion Moonshot Innovators ETF 1.55
XBI D SPDR Series Trust SPDR S&P Biotech ETF 1.52
IDNA D iShares Genomics Immunology and Healthcare ETF 1.38
IBBJ F Defiance Nasdaq Junior Biotechnology ETF 0.62
View all Seasonal/Pandemic Influenza related ETFs...
Compare ETFs
  • Compare GERM to MOON
  • Compare GERM to XBI
  • Compare MOON to IDNA

    • Recent Signals

    Date Stock Signal Type
    2021-03-05 INO Hammer Candlestick Bullish
    2021-03-05 INO Doji - Bullish? Reversal
    2021-03-05 INO Lizard Bullish Bullish Day Trade Setup
    2021-03-05 INO Lower Bollinger Band Walk Weakness
    2021-03-05 VBIV Hammer Candlestick Bullish
    2021-03-05 VBIV Doji - Bullish? Reversal
    2021-03-05 VBIV Lizard Bullish Bullish Day Trade Setup
    2021-03-05 VBIV Lower Bollinger Band Walk Weakness

    Recent News for Seasonal/Pandemic Influenza Stocks

    Date Stock Title
    Mar 4 INO INOVIO to Present at Upcoming Investor Conferences in March
    Mar 3 INO Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
    Mar 2 VBIV VBI Vaccines Stock Could Blast Higher by 170%, Says Analyst
    Mar 2 VBIV VBI Vaccines EPS misses by $0.15, misses on revenue
    Mar 2 INO Why Inovio Stock Is Tanking Today
    Mar 2 VBIV VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
    Mar 2 INO The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
    Mar 2 VBIV VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
    Mar 2 INO Why Inovio's Positive Q4 Update Didn't Impress Investors
    Mar 2 INO Inovio Pharmaceuticals (INO) Q4 2020 Earnings Call Transcript
    Mar 2 INO Inovio Pharmaceuticals' (INO) CEO Joseph Kim on Q4 2020 Results - Earnings Call Transcript
    Mar 1 INO Inovio shares slip afterhours despite positive phase 3 results for VGX-3100
    Mar 1 INO Inovio Reports Q4 Earnings Beat, Mixed REVEAL 1 Data And Coronavirus Vaccine Update
    Mar 1 INO Recap: Inovio Pharmaceuticals Q4 Earnings
    Mar 1 INO UPDATE 1-Inovio completes enrolment in mid-stage U.S. study of COVID-19 vaccine
    Mar 1 INO Inovio Pharmaceuticals EPS beats by $0.08, beats on revenue
    Mar 1 INO INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results
    Mar 1 INO INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18
    Mar 1 INO What You Need To Know In Options This Week: Gamestop, Zoom, Nio, Snowflake, Costco And More
    Mar 1 INO Inovio Tops Estimates; Reports Positive Trial Results
    Related Industries: Biotechnology
    Related Stock Lists: Influenza Influenza Vaccine Medicine Vaccination Vaccine Virology Avian Influenza Biotechnology Cancers Cervical Cancer Clinical Research Coronavirus Cytomegalovirus Infection Diseases Electroporation Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Immunodeficiency

    Browse All Tags